ROBERT POWELL

Issues related to the Farm Credit System and lending authority related to FY 2027 appropriations. Lobbying activities related to lending authority. H.R. 8646 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes. Lobbying activities related to lending authorities.

H.R. 9171 - Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Lobbying activities related to FY 2027 community project funding for water and wastewater improvements in Edmond, Oklahoma. Lobbying activities related to FY 2027 community project funding for water and wastewater improvement in Edmond, Oklahoma.

H.R. 9171 - Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Lobbying activities related to FY 2027 community project funding for water and wastewater improvements in Edmond, Oklahoma. Lobbying activities related to FY 2027 community project funding for water and wastewater improvement in Edmond, Oklahoma.

S. 2431 - Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to FY 2026 community project funding for water and wastewater improvements in Edmond, Oklahoma. H.R. 6938 - Making consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to FY 2026 community project funding for water and wastewater improvements in Edmond, Oklahoma.

H.R. 4121 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to lending authority.

H.R. 4121 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to lending authority.

H.R. 4121 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to lending authority. H.R. 5371 - Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. Lobbying activities related to lending authority.

H.R. 4225 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to FY 2026 community project funding for the modernization of the Edmond Electric substations in Edmond, Oklahoma.

H.R. 4121 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to lending authority. H.R. 5371 - Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. Lobbying activities related to lending authority.

S. 2431 - Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2026, and for other purposes. Lobbying activities related to FY 2026 community project funding for water and wastewater improvements in Edmond, Oklahoma.

Issues related to water and wastewater funding. H.R. 4821 - Making appropriations for the Department of Interior, environment, and related agencies for the fiscal year ending September 30, 2024, and for other purposes - lobbying activities related to community project funding for the Lake Arcadia Water Treatment Plant. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes - lobbying activities related to community project funding for the Lake Arcadia Water Treatment Plant.

Issues related to highway funding. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to community project funding for South Boulevard Improvements. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to highway funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to highway funding. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to community project funding for South Boulevard Improvements. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to highway funding. H.R. ____ - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to community project funding for South Boulevard Improvements. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to airport funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for the Guthrie-Edmond Airport Terminal Expansion. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for the Guthrie-Edmond Airport Terminal Expansion.

Issues related to telematics research funding and highway safety. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to mobile telematics research. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to mobile telematics research.

Issues related to airport funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for the Guthrie-Edmond Airport Terminal Expansion. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for the Guthrie-Edmond Airport Terminal Expansion.

Issues related to telematics research funding and highway safety. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to mobile telematics research. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to mobile telematics research.

Issues related to highway funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to water and wastewater funding. H.R. 4821 - Making appropriations for the Department of Interior, environment, and related agencies for the fiscal year ending September 30, 2024, and for other purposes - lobbying activities related to community project funding for the Lake Arcadia Water Treatment Plant. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes - lobbying activities related to community project funding for the Lake Arcadia Water Treatment Plant.

H.R. 9027 - making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to lending authority of Farm Credit System cooperative banks.

H.R. 9027 - making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to lending authority of Farm Credit System cooperative banks.

Issues related to telematics research funding and highway safety. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to mobile telematics research.

Issues related to telematics research funding and highway safety. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to mobile telematics research.

Issues related to airport funding. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to Guthrie-Edmond Regional Airport.

Issues related to highway funding. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to community project funding for South Boulevard Improvements. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to airport funding. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to Guthrie-Edmond Regional Airport.

Issues related to highway funding. H.R. 9028 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to community project funding for South Boulevard Improvements. H.R. 4366 - Making consolidated appropriations for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to water and wastewater funding. S. 4796 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to community project funding for Edmond Water Treatment Plant.

Issues related to water and wastewater funding. S. 4796 - Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2025, and for other purposes. Lobbying activities related to community project funding for Edmond Water Treatment Plant.

Issues related to airport funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for the Guthrie-Edmond Airport Terminal Expansion.

Issues related to airport funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for the Guthrie-Edmond Airport Terminal Expansion.

Issues related to telematics research funding and highway safety. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to mobile telematics research.

Issues related to highway funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to highway funding. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to community project funding for I-35 improvements.

Issues related to telematics research funding and highway safety. H.R. 4820 - Making appropriations for the Department of Transportation, and House and Urban Development, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. Lobbying activities related to mobile telematics research.

Issues related to water and wastewater funding. H.R. 4821 - Making appropriations for the Department of Interior, environment, and related agencies for the fiscal year ending September 30, 2024, and for other purposes - lobbying activities related to community project funding for the Lake Arcadia Water Treatment Plant.

Issues related to water and wastewater funding. H.R. 4821 - Making appropriations for the Department of Interior, environment, and related agencies for the fiscal year ending September 30, 2024, and for other purposes - lobbying activities related to community project funding for the Lake Arcadia Water Treatment Plant.

Issues related to broadband. H.R. 2471 - Consolidated Appropriations Act, 2022 (Lobbying activities related to the FY-22 broadband funding)

Issues related to broadband. H.R. 2471 - Consolidated Appropriations Act, 2022 (Lobbying activities related to the FY-22 broadband funding)

Issues related to energy efficiency. H.R. 2471 - Consolidated Appropriations Act, 2022 (Lobbying activities related to the Energy Resilience and Conservation Investment Program)

Issues related to broadband. H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes. (Lobbying activities related to the FY-23 broadband funding) H.R. 2617 - Consolidated Appro5 priations Act, 2023. (Lobbying activities related to the FY-23 broadband funding)

Funding related to water and waste water infrastructure. HR 8262 - Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2023, and for other purposes. (Lobbying activities related to Community Project Funding for the City fo Edmond Water Treatment Plant Expansion.) H.R. 2617 - Consolidated Appro5 priations Act, 2023. (Lobbying activities related to Community Project Funding for the City fo Edmond Water Treatment Plant Expansion.)

Issues related to broadband. H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes. (Lobbying activities related to the FY-23 broadband funding) H.R. 2617 - Consolidated Appro5 priations Act, 2023. (Lobbying activities related to the FY-23 broadband funding)

Issues related to broadband. H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes. (Lobbying activities related to the FY-23 broadband funding)

Funding related to water and waste water infrastructure. HR 8262 - Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2023, and for other purposes. (Lobbying activities related to Community Project Funding for the City fo Edmond Water Treatment Plant Expansion.) H.R. 2617 - Consolidated Appro5 priations Act, 2023. (Lobbying activities related to Community Project Funding for the City fo Edmond Water Treatment Plant Expansion.)

Funding related to water and waste water infrastructure. HR 8262 - Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2023, and for other purposes. (Lobbying activities related to Community Project Funding for the City fo Edmond Water Treatment Plant Expansion.)

Issues related to energy efficiency. H.R. 4355 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2022, and for other purposes. (Lobbying activities related to the Energy Resilience and Conservation Investment Program)

Issues related to energy efficiency. H.R. 4355 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2022, and for other purposes. (Lobbying activities related to the Energy Resilience and Conservation Investment Program)

Issues related to energy efficiency. H.R. 4355 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2022, and for other purposes. (Lobbying activities related to the Energy Resilience and Conservation Investment Program)

Issues related to broadband. H.R. 4356 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2022, and for other purposes. (Lobbying activities related to the FY-22 broadband funding)

Issues related to broadband. H.R. 4356 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2022, and for other purposes. (Lobbying activities related to the FY-22 broadband funding)

Issues related to broadband. H.R. 4356 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2022, and for other purposes. (Lobbying activities related to the FY-22 broadband funding)

Legislation H.R. 3164 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 2740 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to the FY 2020 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 3164 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 2740 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to the FY 2020 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 3164 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 2740 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to the FY 2020 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 3164 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 2740 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2020, and for other purposes. (Lobbying activities related to the FY 2020 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 1625 - Consolidated Appropriations Act, 2018 (Lobbying activities related to the FY 2018 appropriations for the Centers for Disease Control, and protecting the Food and Drug Administration's full authority over tobacco products.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 1625 - Consolidated Appropriations Act, 2018 (Lobbying activities related to the FY 2018 appropriations for the Centers for Disease Control, and protecting the Food and Drug Administration's full authority over tobacco products.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. ____ - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. ____ - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5961 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to protecting the Food and Drug Administration's full authority over tobacco products.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to the FY 2019 appropriations for the Centers for Disease Control.) Issues FDA regulation of tobacco products Tobaccos role in health disparities

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees

Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees